Short-term observation of electric ablation with nanosecond pulsed electric field (nsPEF) on hepatic hilar area

Jiahua Lu,Junjie Qian,Shiyu Zhang,Xinhua Chen,Shengyong Yin,Lin Zhou,Shusen Zheng,Wu Zhang

DOI: https://doi.org/10.21203/rs.2.23523/v2

2020-01-01

Abstract:Abstract Background: Treatment of liver malignancies located at the hepatic hilar area has long been recognized as a challenge for both surgeons and interventional radiologists. Traditional locoregional thermal ablative therapies like radiofrequency ablation (RFA) have natural deficiencies to achieve complete ablation. Nanosecond pulsed electric field (nsPEF) has emerged as a novel electric power based locoregional therapy. It has been reported to effectively ablate liver malignancies while its effect on tumors located in hepatic hilar areas still lacks well-controlled follow-up studies. Methods: This pre-clinical study was conducted to evaluate the safety and feasibility of nsPEF ablation in the hepatic hilar area and to investigate its effect on liver vasculature systems. Two-needle electrodes of the nsPEF were placed around the hepatic hilar areas in the rabbit liver under ultrasonic guidance. During and after the procedure of nsPEF ablation, electrocardiographs (ECG) was used to monitor cardiovascular activities and ultrasonography was used to detect vascular changes. The blood samples and liver specimens were collected at pre-treatment and at 2 hours, 2 days, 7 days, 14 days and 28 days post-treatment. Results: Histopathological studies showed the targeted portal area was ablated accurately without perivascular sparing. The major structures of the large hepatic veins and bile ducts near hilar areas were preserved well. Follow-up biochemical tests showed a transient and mild impairment of liver function. The results of myocardial enzymes and routine blood test proved nsPEF won’t cause collateral damage on cardiac systems or increase potential infection risk. Ultrasonography and electrocardiographs found no massive hemorrhea and abnormal cardiac activities. Conclusion: Our results demonstrate that nsPEF is safe and feasible in the ablation of large animal models. During the treatment, nsPEF would not disturb vital organ functions or cause irreversible complications. Furthermore, it can ablate the hepatic hilar area without damaging large hepatic vasculatures, which could be a promising method for non-thermal tumor ablation.